2024/10/04 08:08:17 | |
---|---|
Price | |
143.65 EUR | |
Difference | 0.17% (0.25) |
ISIN | US23918K1088 |
Symbol | DVA |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 12,217 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 146.10 EUR (210) |
Ask (Ask size) | 146.60 EUR (210) |
Open | 143.65 EUR |
High | 143.65 EUR |
Low | 143.65 EUR |
Close (prev. day) | 143.40 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/04 08:08:17 | |
---|---|
Price | |
143.65 EUR | |
Difference | 0.17% (0.25) |
ISIN | US23918K1088 |
Symbol | DVA |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 12,217 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 146.10 EUR (210) |
Ask (Ask size) | 146.60 EUR (210) |
Open | 143.65 EUR |
High | 143.65 EUR |
Low | 143.65 EUR |
Close (prev. day) | 143.40 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +15.52% | +61.66% | +43.58% |
Perf (abs.) | +19.30 | +54.79 | +43.60 |
Beta | 0.36 | 0.45 | 0.52 |
Volatility | 29.36 | 32.59 | 37.59 |
Ø price 5 days | Ø volume 5 days (pcs.) | 145.07 EUR (8) |
Ø price 30 days | Ø volume 30 days (pcs.) | 141.32 EUR (5) |
Ø price 100 days | Ø volume 100 days (pcs.) | 133.02 EUR (1) |
Ø price 250 days | Ø volume 250 days (pcs.) | 115.65 EUR (10) |
YTD High | date | 147.70 EUR (2024/09/17) |
YTD Low | date | 94.54 EUR (2024/01/02) |
52 Weeks High | date | 147.70 EUR (2024/09/17) |
52 Weeks Low | date | 69.26 EUR (2023/10/16) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/10/04 | 22:26 | 146.35 EUR | 0.00 | 2 |
Stuttgart | 2024/10/04 | 20:15 | 145.85 EUR | 0.00 | 5 |
NYSE | 2024/10/04 | 22:00 | 160.69 USD | 62.79 | 10,448 |
Munich | 2024/10/04 | 08:01 | 144.70 EUR | 0.00 | 1 |
London Stock Exchange | 2024/09/05 | 11:48 | 151.37 USD | 0.16 | 1 |
Hanover | 2024/10/04 | 17:25 | 145.75 EUR | 0.00 | 4 |
Frankfurt | 2024/10/04 | 08:20 | 143.60 EUR | 0.00 | 2 |
Duesseldorf | 2024/10/04 | 08:10 | 143.60 EUR | 0.00 | 1 |
Berlin | 2024/10/04 | 08:08 | 143.65 EUR | 0.00 | 2 |
DAVITA INC. |
- - |
2000 16th Street - 80202-7198 Denver |
Telefon: +1-720-631-2100 |
Fax: + |
E-mail: - |
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO. |
Pamela Arway | Chairman of Board of Directors |
Gregory Moore | Member of Board of Directors |
Adam Schechter | Member of Board of Directors |
Barbara Desoer | Member of Board of Directors |
Charles Berg | Member of Board of Directors |
Dennis Pullin | Member of Board of Directors |
Jason Hollar | Member of Board of Directors |
Phyllis Yale | Member of Board of Directors |
Wendy Schoppert | Member of Board of Directors |
Javier J. Rodriguez | Chairman of Managing Board |
Christopher M. Berry | Member of Executive Committee |
James O. Hearty | Member of Executive Committee |
Jeffrey A. Giullian | Member of Executive Committee |
Joel Ackerman | Member of Executive Committee |
Kathleen A. Waters | Member of Executive Committee |
Kenny Gardner | Member of Executive Committee |
Michael D. Staffieri | Member of Executive Committee |
Robert Lang | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer